Search

everythinglearnresearchcommunity

for

Search:↓

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

New therapies are being developed that target integrin pathways to treat various diseases.

Sudden, unusual hair loss may indicate serious underlying health issues.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

AGEs may cause hair loss by increasing inflammation in hair follicles.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

The document provides 70 multiple choice questions to improve haematology skills.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.